Andrew Bluj
About Andrew Bluj
Andrew Bluj is an Associate Director of Analytical Quality Assurance at both Bristol Myers Squibb and Mirati Therapeutics, with extensive experience in quality control and analytical chemistry.
Title
Andrew Bluj currently holds the position of Associate Director, Analytical Quality Assurance at Bristol Myers Squibb and Mirati Therapeutics.
Current Employment
Andrew Bluj is currently employed as an Associate Director, Analytical Quality Assurance at both Bristol Myers Squibb in the United States and Mirati Therapeutics in San Diego, California, United States.
Previous Experience
Andrew Bluj has held various positions throughout his career. He served as Associate Director, Quality Control, CMC at Esperion - The Lipid Management Company from 2019 to 2022. Prior to that, he worked at Emergent BioSolutions in several roles, including Senior Manager, Quality Control in 2019, Manager, QC Analytical Chemistry from 2016 to 2019, and Supervisor QC Chemistry, Product Testing in 2016. He also worked as a Site Chemist, Analytical/Validation – Quality Dept at Dow from 2011 to 2016, Tech Services Scientist / Chemist / Microbiologist at Teva Pharmaceuticals from 2006 to 2011, and Biochemist, Antibody R&D at Cayman Chemical in 2006.
Education and Expertise
Andrew Bluj earned an MBA in Pharmaceutical & Healthcare Business from the University of the Sciences in Philadelphia from 2010 to 2012. He also holds a BS in Biochemistry & Molecular Biology/Biotechnology and a Bachelor's degree in Chemistry, both from Michigan State University. He possesses a Six Sigma Black Belt and has expertise in process improvement and quality management. He has significant experience in method development, validation, and troubleshooting across various sectors such as specialty chemicals, pharmaceuticals, API, excipient, and medical devices.
Professional Contributions
Andrew Bluj has served as a US Pharmacopeia Scientific Expert Committee Member, contributing to the development and revision of pharmaceutical standards. He has participated in quality audits to ensure compliance with industry regulations, including cGMP, cGLP, FDA, ICH, USP/EP/JP, and 21 CFR Parts 210 & 211, supported microbiological testing for 3 years, and has a diverse skill set in quality control and analytical chemistry.